Shandong Lukang Pharmaceutical Co., Ltd. Class ASSE: 600789

Reply to SSE Inquiry Letter on Ex Post Audit of the Company's 2024 Annual Report

· Issued by Shandong Lukang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Reply to SSE Inquiry Letter on Ex Post Audit of the Company's 2024 Annual Report

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment